← Home
/
MOONLAKE IMMUNOTHERAPEUTICS (MLTX)
Stock Analysis
MOONLAKE IMMUNOTHERAPEUTICS (MLTX)
MLTX
MLTX · Market data
19.19
+1.11%
Updated: 2026-06-18 13:38 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 21.64. Holding above 19.01 keeps the current thesis intact.
✓
Fundamentals
Insufficient / Insufficient
✓
Price Structure
Constructive
×
Breakout Confirmation
Pending
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
19.01
↗
Break Above
Confirmation improves above resistance.
21.64
🎯
Next Objective
Pattern-derived target if setup continues.
23.44
×
Thesis Break
Scenario weakens below invalidation.
Below 19.01
What's Driving MLTX?
📈 Technical recovery is improving
Momentum is Neutral. Watch 21.64 for confirmation and 19.01 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 17.91 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Pattern
Triangle Compression / SYM / UP
Breakout Watch
Downtrend line not broken yet · score 0
◎
How to read this setup
From a roadmap perspective, the setup is boxed by support near 17.91 and resistance around 21.64. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Insufficient
●
Profitability
Insufficient
📈 Net Income
-69.71M
≈ Insufficient
🧮 EPS (Basic)
-0.98
≈ Insufficient
MOONLAKE IMMUNOTHERAPEUTICS
Note: This is an algorithmic technical snapshot, not financial advice.